- Validation of the MLL-LEDGF/p75 interaction as a therapeutic target for Mixed Lineage Leukemia(2016)
Auteurs: Sara Elashkar, Jan De Rijck, Katerina Cermakova, Petr Tesina, Jonas Demeulemeester, Helene Mereau, Jürg Schwaller, Vaclav Ververka, Pavlina Rezacova, Zeger Debyser
Pagina's: S69 - S69
- Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif(2015)
Auteurs: Katerina Cermakova, Subhalakshmi Sharma, Frauke Christ, Jonas Demeulemeester, Zeger Debyser, Jan De Rijck
Pagina's: 7968
- Validation and structural characterisation of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia(2014)
Auteurs: Katerina Cermakova, Jonas Demeulemeester, Sara Elashkar, Jan De Rijck
Pagina's: 5139 - 5151
- Detargeted Integration of MLV-Based Vectors By Integrase Mutants That Disrupt BET Protein Interaction(2014)
Auteurs: Sara El Ashkar, Jan De Rijck, Jonas Demeulemeester, Sofie Vets, Katerina Cermakova, Christine de Kogel, Zeger Debyser, Rik Gijsbers
Pagina's: S210 - S211
- Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia(2014)
Auteurs: Katerina Cermakova, Petr Tesina, Jonas Demeulemeester, Sara Elashkar, Helene Mereau, Juerg Schwaller, Pavlina Rezacova, Vaclav Veverka, Jan De Rijck
Pagina's: 5139 - 5151
- BET-independent MLV-based vectors target away from promoters and regulatory elements(2014)
Auteurs: Sara Elashkar, Jan De Rijck, Jonas Demeulemeester, Sofie Vets, Paradise Madlala, Katerina Cermakova, Zeger Debyser, Rik Gijsbers
- Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia(2014)
Auteurs: Katerina Cermakova, Petr Tesina, Jonas Demeulemeester, Sara Elashkar, Helene Mereau, Juerg Schwaller, Pavlina Rezacova, Vaclav Veverka, Jan De Rijck
Pagina's: 5139 - 5151